[1] 杜亚松,曹阳,江文庆. 注意缺陷多动障碍儿童的执行功能[J]. 中国儿童保健杂志, 2019, 27(5):465-468,472. [2] 王玉凤. 注意缺陷多动障碍[M]. 北京: 北京大学医学出版社, 2019. [3] Coghill DR, Seth S, Pedroso S, et al. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder:Evidence from a systematic review and a meta-analysis[J]. Biol Psychiat, 2014, 76(8):603-615. [4] Rosenau PT, Openneer TJC, Matthijssen AM, et al. Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use:A randomized, placebo-controlled discontinuation study[J]. J Child Psychol Psychiatry, 2021, 62(12):1444-1452. [5] Ünal D, Mustafaoğlu Çiçek N, Çak T, et al. Comparative analysis of the WISC-Ⅳ in a clinical setting: ADHD vs. non-ADHD[J]. Arch Pediatr, 2021, 28(1):16-22. [6] Hall CL, Guo B, Valentine AZ, et al. The validity of the SNAP-Ⅳ in children displaying ADHD symptoms[J]. Assessment, 2020, 27(6):1258-1271. [7] Izzo VA, Donati MA, Primi C. Assessing ADHD through the multi-informant approach: The Contribution of the Conners′ 3 Scales[J]. J Atten Disord, 2019, 23(6):641-650. [8] Periáñez JA, Lubrini G, García-Gutiérrez A, et al. Construct validity of the Stroop Color-Word Test: Influence of Speed of visual search, verbal fluency, working memory, cognitive flexibility, and conflict monitoring [J]. Arch Clin Neuropsychol, 2021, 36(1):99-111. [9] Arán Filippetti V, Krumm GL, Raimondi W. Computerized versus manual versions of the Wisconsin Card Sorting Test: Implications with typically developing and ADHD children[J]. Appl Neuropsychol Child, 2020,9(3):230-245. [10] Wells EL, Kofler MJ, Soto EF, et al. Assessing working memory in children with ADHD: Minor administration and scoring changes may improve digit span backward′s construct validity[J]. Res Dev Disabil, 2018, 72:166-178. [11] Kofler MJ, Sarver DE, Harmon SL, et al. Working memory and organizational skills problems in ADHD [J]. J Child Psychol Psychiatry, 2018, 59(1):57-67. [12] Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults:A systematic review and network meta-analysis. [J]. Lancet Psychiatry, 2018, 5(9):727-738. [13] Taş Torun Y, Işik Taner Y, Güney E, et al. Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in ADHD: A randomized controlled trial[J]. Appl Neuropsychol Child, 2020, 6:1-12. [14] 赵滢, 杜亚松, 蒋良函, 等. 盐酸托莫西汀对注意缺陷多动障碍儿童行为特征的影响[J]. 临床精神医学杂志, 2011, 21(4):240-242. [15] Huang YS, Yeh CB, Chen CH, et al. A randomized, double-blind, placebo-controlled, two-way crossover clinical trial of ORADUR-Methylphenidate for treating children and adolescents with attention-deficit/hyperactivity disorder[J]. J Child Adolesc Psychopharmacol, 2021,31(3):164-178. [16] Brown TE,Holdnack J,Saylor K,et al. Effect of Atomoxetine on executive function impairments in adults with ADHD [J]. J Atten Disord, 2011, 15(2) :130-138. [17] Griffiths KR, Leikauf JE, Tsang TW, et al. Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial[J]. J Psychiatr Res, 2018, 102:57-64. [18] Rubio Morell B, Hernández Expósito S. Differential long-term medication impact on executive function and delay aversion in ADHD[J]. Appl Neuropsychol Child, 2019, 8(2):140-157. [19] Kratz O, Studer P, Baack J, et al. Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD:An event-related potential study using the Attention Network Test[J]. Prog neuropsychopharmacol boilpsychiatry, 2012, 37(1):81-89. [20] Ni HC,Shang CY,Gau SS, et al. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder [J]. Int J Neuropsychopharmacol, 2013, 16(9):1959-1973. [21] Wu CS, Shang CY, Lin HY, et al. Differential treatment effects of Methylphenidate and Atomoxetine on executive functions in children with attention-deficit/hyperactivity disorder[J]. J Child Adolesc Psychopharmacol, 2021, 31(3):187-196. [22] Kowalczyk OS, Cubillo AI, Smith A, et al. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents[J]. Eur Neuropsychopharmacol, 2019, 29(10):1102-1116. |